Nationwide Fund Advisors’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-62,716
Closed -$5.7M 2213
2017
Q3
$5.7M Sell
62,716
-526
-0.8% -$45K 0.02% 964
2017
Q2
$4.71M Buy
63,242
+9,245
+17% +$741K 0.02% 1043
2017
Q1
$5.06M Sell
53,997
-1,035
-2% -$93.8K 0.02% 982
2016
Q4
$4M Sell
55,032
-44,876
-45% -$3.84M 0.02% 1107
2016
Q3
$10.4M Sell
99,908
-52,101
-34% -$4.71M 0.04% 595
2016
Q2
$11.2M Buy
152,009
+41,675
+38% +$2.83M 0.05% 532
2016
Q1
$6.22M Buy
110,334
+99,588
+927% +$5.87M 0.03% 821
2015
Q4
$725K Buy
10,746
+253
+2% +$13.5K ﹤0.01% 1897
2015
Q3
$487K Buy
10,493
+668
+7% +$32.4K ﹤0.01% 2134
2015
Q2
$528K Buy
9,825
+3,884
+65% +$198K ﹤0.01% 2218
2015
Q1
$285K Sell
5,941
-83
-1% -$3.6K ﹤0.01% 2518
2014
Q4
$233K Buy
+6,024
New +$190K ﹤0.01% 2545

Other funds holding NVRO

Nationwide Fund Advisors's NVRO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of NEVRO CORP. (NVRO) in Q4 2017, closing a stake of 62,716 shares — an estimated $5.7M sold.

Nationwide Fund Advisors first reported a position in NVRO in Q4 2014 and held it in 12 quarters. The position peaked at $11.2M in Q2 2016. 194 funds tracked by Wall St. Rank hold NVRO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining NEVRO CORP. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 62,716 NEVRO CORP. shares in Q4 2017, an estimated $5.7M.
  • Nationwide Fund Advisors first reported a position in NEVRO CORP. in Q4 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's NEVRO CORP. position peaked at $11.2M in Q2 2016.
  • 194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.